CAROLINE CONKWRIGHT: Open Payments
NPI 1205235215 · KITTY HAWK, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,921 in 91 payments from 18 companies in 2025. Trend: 2023 $1,685 · 2024 $1,632 · 2025 $1,921
Food & beverage: $1,921
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $395 |
| Galderma Laboratories, L.P. | 14 | $331 |
| Janssen Biotech, Inc. | 12 | $229 |
| REVANCE THERAPEUTICS, INC. | 11 | $220 |
| Novartis Pharmaceuticals Corporation | 9 | $202 |
| GENZYME CORPORATION | 5 | $110 |
| Incyte Corporation | 3 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $55 |
| Amgen Inc. | 2 | $43 |
| UCB, Inc. | 1 | $41 |
Products named: RINVOQ, TREMFYA, DAXXIFY, NEMLUVIO, DUPIXENT, OPZELURA, SKYRIZI, Rhapsido.
Industry payments across NC — which companies pay providers there.
